Information Provided By:
Fly News Breaks for June 26, 2017
DVA
Jun 26, 2017 | 05:39 EDT
Jefferies analyst Chris Cooper downgraded DaVita to Hold citing slowing treatment growth and the "tight" rate environment. The analyst believes a less competitive cost base and patient steering allegations are hindering the company's rate negotiations. He sees risk to consensus estimates and keeps a $70 price target for DaVita shares.
News For DVA From the Last 2 Days
There are no results for your query DVA